Caval valve implantation for percutaneous treatment of tricuspid regurgitation: preprocedural anatomical assessment.

Rev Esp Cardiol (Engl Ed)

Departamento de Cardiología, Hospital Clínico Universitario, Valladolid, Spain; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Spain. Electronic address:

Published: September 2021

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rec.2021.01.009DOI Listing

Publication Analysis

Top Keywords

caval valve
4
valve implantation
4
implantation percutaneous
4
percutaneous treatment
4
treatment tricuspid
4
tricuspid regurgitation
4
regurgitation preprocedural
4
preprocedural anatomical
4
anatomical assessment
4
caval
1

Similar Publications

Transcatheter caval valve implantation (CAVI) is an emerging treatment option for inoperable patients with severe tricuspid regurgitation (TR). We present a case of a 76-year-old lady with severe TR and recurrent right heart failure who improved after CAVI. This is the first such case in a rare environment.

View Article and Find Full Text PDF

During surgery for oval fossa defects, inadvertent suturing of pericardial patches to a prominent Eustachian valve diverts the inferior vena caval blood to the left atrium causing iatrogenic cyanosis. A similar complication may arise after surgery for superior sinus venosus defects. Surgical patch in a wrong plane may direct the superior vena cava towards the left atrium.

View Article and Find Full Text PDF

Objective: We aimed to explore the feasibility of an inverted-T upper hemisternotomy approach for pulmonary endarterectomy (PEA) and report the results after 17 cases.

Methods: PEA was conducted through a 7-cm skin incision using an inverted-T upper hemisternotomy across the third intercostal spaces. Cardiopulmonary bypass (CPB) was established through central arterial and percutaneous femoral dual-staged venous cannulation.

View Article and Find Full Text PDF

Exercise testing in patients with tricuspid regurgitation undergoing transcatheter tricuspid valve intervention.

Clin Res Cardiol

October 2024

Clinic for General and Interventional Cardiology/Angiology, Herz- Und Diabeteszentrum NRW, Ruhr-Universität Bochum, Med. Fakultät OWL (Universität Bielefeld), Georgstraße 11, 32545, Bad Oeynhausen, Germany.

Background: Transcatheter tricuspid valve intervention (TTVI) has shown promising results with persistent reduction of tricuspid regurgitation (TR) and improvements in functional class and quality of life (QOL).

Objectives: To analyze the impact of TTVI on maximal and submaximal exercise capacity (SEC).

Methods: Constant work-rate exercise-time (CWRET) testing reflects SEC, which is more likely to be relevant for daily life activities and provides more differentiated physiological insight into the nature of exercise intolerance.

View Article and Find Full Text PDF

The Current Landscape of Transcatheter Tricuspid Valve Intervention.

J Soc Cardiovasc Angiogr Interv

December 2023

Section of Cardiovascular Medicine, Yale School of Medicine, Yale University, New Haven, Connecticut.

Tricuspid regurgitation (TR) is common, and its prevalence increases with age. It was previously estimated that there are 1.6 million patients in the United States with moderate or worse TR, and more contemporary data suggest the age-adjusted prevalence of TR is 0.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!